Challenges And Opportunities As mRNA Manufacturing Spreads Its Wings Beyond COVID-19 Vaccines

In the second part of In Vivo's series on mRNA manufacturing, we look at the technology behind the Moderna and Pfizer/BioNTech COVID-19 vaccines. Experts in the field are working on a variety of improvements that will enable quicker, cheaper, surer development and production of what could turn out to be a wide array of vaccines and therapeutics to be churned out by emerging mRNA platforms.

Butterfly hand
Having emerged, mRNA is now preparing for wider horizons • Source: Shutterstock

Now that new mRNA manufacturing technologies have come seemingly out of nowhere to quickly produce billions of COVID-19 vaccine doses, companies are working to optimize them into robust platform technologies that could produce a whirlwind of innovative drug products now under development.

In a recent discussion on easing bottlenecks to meet the potential of mRNA, an expert panel explored a range...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Manufacturing Focus

Why CAR T Therapies Are Hard To Scale, And How Challenges Can Be Solved

 

Chimeric antigen receptor T-cell (CAR-T) therapies have revolutionized the treatment of blood cancer, but scalability remains a major challenge. Experts explain how technologies such as chip-based miniaturized models and automation could be part of the solution.  

How Cellino’s Cassette Technology Will Impact Regenerative Medicine

 
• By 

Co-founder and CEO of Cellino Biotech, Nabiha Saklayen, discusses the company’s innovative platform which uses automated technologies to overcome challenges in the development of regenerative medicine.

Agnė Vaitkevičienė: The Versatile CEO Driving Memel Biotech

 

Rising star Agnė Vaitkevičienė is juggling roles as the CEO of an emerging Lithuanian biotech, with work for a partner company, the national biotech trade association and much more.   

China VBP, Localization And Other Strategies - How Far And Which Way?

 
• By 

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues. 

More from In Vivo

XXXXtesting

 
• By 

XXXXtesting

In Vivo’s 2026 Rising Leaders At A Glance

 
• By 

Top 30 leaders: see the list of industry influencers highlighted in the sixth edition of In Vivo's Rising Leaders series.

InVivo-Innovation-Free: ‘Interview’ article that includes different Composer content

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.